Novel Approaches To Design Glycan‐Based Antibacterial Inhibitors

Abstract

AbstractThe interactions between bacterial lectins and carbohydrates on the host cell surface can mediate bacterial adhesion, invasion, and immune evasion. Multivalency plays a key role in these binding events. However, additional molecular mechanisms greatly impact multivalent binding recognition. To develop specific and effective bacterial inhibitors, a deeper understanding of the complex underlying mechanisms of bacterial adhesion processes is necessary. By interfering with bacterial adhesion, synthetic multivalent glycoconjugates do not only have the potential to improve or replace antibiotic treatments, but also represent useful tools to study carbohydrate‐pathogen interactions. In this review, we highlight a few recent advances in the synthesis and application of synthetic glycan‐based scaffolds to uncover the nature of glycan‐bacteria interactions and to design efficient bacterial inhibitors.